|
|
Volumn 88, Issue 2, 2008, Pages 117-118
|
|
Kanamycin
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CEPHALOSPORIN;
ISONIAZID;
KANAMYCIN;
KANAMYCIN A;
KANAMYCIN B;
KANAMYCIN BASE;
KANAMYCIN C;
KANAMYCIN DERIVATIVE;
KENAMYCIN A;
PENICILLIN G;
ACINETOBACTER;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ANTIBACTERIAL ACTIVITY;
ANTIBIOTIC RESISTANCE;
ANTIMICROBIAL ACTIVITY;
AREA UNDER THE CURVE;
BACTERIAL ENDOCARDITIS;
BACTERICIDAL ACTIVITY;
BINDING AFFINITY;
CROSS RESISTANCE;
DRUG ABSORPTION;
DRUG ACTIVITY;
DRUG BLOOD LEVEL;
DRUG CLEARANCE;
DRUG EFFICACY;
DRUG HALF LIFE;
DRUG MECHANISM;
DRUG METABOLISM;
DRUG POTENCY;
DRUG POTENTIATION;
DRUG SAFETY;
DRUG SOLUBILITY;
ENTEROBACTER;
GUINEA PIG;
HUMAN;
INTESTINE INJURY;
INTESTINE OBSTRUCTION;
KIDNEY FAILURE;
LUNG TUBERCULOSIS;
MINIMUM INHIBITORY CONCENTRATION;
MOLECULAR WEIGHT;
MOUSE;
MYCOBACTERIUM TUBERCULOSIS;
NONHUMAN;
OTOTOXICITY;
PLASMA HALF LIFE;
PRIORITY JOURNAL;
PROTEIN SYNTHESIS INHIBITION;
PSEUDOMONAS;
RABBIT;
REVIEW;
STREPTOCOCCUS INFECTION;
URINARY EXCRETION;
VESTIBULOCOCHLEAR NERVE DISEASE;
ANIMALS;
ANTITUBERCULAR AGENTS;
HUMANS;
KANAMYCIN;
TREATMENT OUTCOME;
TUBERCULOSIS;
|
|
EID: 43249107477
PISSN: 14729792
EISSN: None
Source Type: Journal
DOI: 10.1016/S1472-9792(08)70012-X Document Type: Review |
|
Times cited : (9)
|
|
References (6)
|
